I Saldi Cambiamento Data
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 120.88M 26.41M 2026-06
Baxter International USD 2.98B 20M 2026-09
Bayer EUR 10.05B 820M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Insmed USD 524.42M 98.93M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
J&J USD 25.4B 89M 2026-09
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Moderna USD 1.31M 98.69M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Teva Pharmaceutical Industries USD 4.37B 8.3B 2026-09
United Therapeutics USD 832.5M 49.2M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09